The unified social credit code/registration number of Wuhan Hengxinyuan Pharmaceutical Co., Ltd. is 914201005550243488, and the enterprise is in the opening state.
The business scope of Wuhan Hengxinyuan Pharmaceutical Co., Ltd. is: the production of small-volume injections, raw materials (tromethamine ozagrel, dantraline sodium) and hard capsules (operated within the approved time limit with a license); New drug research and development and technical services. (Projects subject to examination and approval according to law can only be operated after examination and approval by relevant departments). In Hubei Province, the total registered capital of companies with similar business scope is 12,277,300 yuan, and the main capital is concentrated in enterprises with a scale of more than 50 million, with12. In the province, the registered capital of enterprises is good at present.
Wuhan Hengxinyuan Pharmaceutical Co., Ltd. invested in 2 foreign companies and 0 branches.
See more information and materials of Wuhan Hengxinyuan Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.